Cytotoxic effects of delphinidin in human osteosarcoma cells

Area of Science:

• Biochemistry
• Cell Biology
• Oncology

Background:

• Osteosarcoma is a primary bone malignancy with limited treatment options.
• Delphinidin, a plant-derived flavonoid, has shown potential anti-cancer properties.
• Understanding delphinidin's effects on osteosarcoma cells is crucial for therapeutic development.

Purpose of the Study:

• To determine if delphinidin is cytoprotective or cytotoxic to osteosarcoma cell lines.
• To investigate the mechanisms underlying delphinidin's effects, focusing on apoptosis and autophagy.
• To evaluate delphinidin's role in reactive oxygen species (ROS) generation and cell cycle progression.

Main Methods:

• Human osteosarcoma cell lines were treated with varying concentrations of delphinidin.
• Apoptosis and autophagy were assessed using specific markers and inhibitors (3-methyladenine, bafilomycin A1).
• Cell viability, LC3-II expression, ROS levels, and cell cycle distribution were analyzed.

Main Results:

• Delphinidin demonstrated dose-dependent cytotoxicity against osteosarcoma cells.
• The compound induced apoptosis, which was linked to increased ROS accumulation.
• Delphinidin triggered autophagosome formation and LC3-II conversion, but autophagy did not mediate the cytotoxic effect.

Conclusions:

• Delphinidin inhibits cellular protective mechanisms, specifically autophagy, leading to ROS accumulation and enhanced apoptotic cell death.
• These findings suggest delphinidin's potential as a chemotherapeutic agent for osteosarcoma.
• Delphinidin may prevent osteosarcoma development and progression by disrupting cellular defense pathways.